# com.phasefolio/phasefolio

> Biotech rNPV/PoS engine for AI agents. Signed exports, evidence register, asset landscape.

- name: com.phasefolio/phasefolio
- version: 0.1.4
- connection class: R0 (autonomous)
- trust: 76/100 flags: no-repository
- quality: 88/100 (good)
- owner: not claimed
- descriptor: https://api.protogrid.dev/v1/servers/com.phasefolio%2Fphasefolio
- tools: https://api.protogrid.dev/v1/servers/com.phasefolio%2Fphasefolio/tools

**An agent can connect right now, no human step.** Remote endpoint, no authentication, reachable on the last probe.

## Connection (mcpServers)

```json
{
  "mcpServers": {
    "phasefolio": {
      "type": "http",
      "url": "https://app.phasefolio.com/api/mcp",
      "headers": {
        "Authorization": "Bearer ${PHASEFOLIO_TOKEN}"
      }
    }
  }
}
```

Placeholders to fill: `${PHASEFOLIO_TOKEN}`.

## Trust

- hygiene: 80
- liveness: 100
- freshness: 65
- provenance: 55
- drivers: +dns-namespace +website +reachable +uptime-100% ~updated-170d-ago -no-repository
- Derived from observable signals (official registry feed and our own credential-free probes); no code audit performed.

## Quality 88/100 (good)

### protocol: 75 (weight 25)

- warn `protocol.modern`: newest supported version is 2024-11-05; 2026-07-28 not supported, older versions are deprecated until 2027-07-28
- n/a `protocol.stateless`: only applies to 2026-07-28 servers
- pass `protocol.transport`: streamable HTTP
- n/a `protocol.list_ttl`: only applies to 2026-07-28 servers

### authorization: n/a (weight 15)

- n/a `auth.prm`, `auth.as_metadata`, `auth.cimd`: no remote uses OAuth
- n/a `auth.secret_in_url`: no templated URL

### tool hygiene: 100 (weight 30)

- pass `tools.descriptions`: every tool has a description
- pass `tools.description_length`: descriptions are concise
- pass `tools.schemas`: every tool has an object input schema
- pass `tools.annotations`: 10 of 10 tools declare readOnlyHint or destructiveHint
- pass `tools.directory_hints`: every tool declares readOnlyHint, destructiveHint, idempotentHint and openWorldHint
- pass `tools.token_cost`: about 3,010 tokens to load every tool
- pass `tools.api_dump`: tools are not a one-to-one API dump

### stability: 75 (weight 15)

- warn `stability.changes`: 13 tool changes in 30 days
- pass `stability.rug_pull`: no tool changed its meaning under the same name

### dependencies: 100 (weight 15)

- pass `deps.known_vulns`: no known advisory in 85 resolved packages
- n/a `deps.mcp_sdk_version`: the official MCP SDK is not in the dependency graph
- pass `deps.resolvable`: @phasefolio/mcp@0.1.4 resolved: 85 packages

- tools: 10, about 3,010 tokens to load them all
- tool set hash: 0e4d4874ae64253bc777fb717758c646
- tools last changed: 2026-09-28T12:30:48.285Z
- badge: [![protogrid quality](https://protogrid.dev/badge/com.phasefolio/phasefolio.svg)](https://protogrid.dev/servers/com.phasefolio/phasefolio)
- Checks run on what our credential-free, read-only probes observe; tools are never called and no code audit is performed.

### Tool changes

- 2026-09-28 `get_methodology` changed (description, inputSchema, outputSchema)
  - before: Fetch a PhaseFolio methodology section's full content (rNPV model, backtest, PoS calibration, IRA framework, development paths, deal-term modelling, clinical stage normalization, evidence standards, network benchmarks, COGS benchmark, SG&A benchmark, tax benchmark, SEC EDGAR deal-term extraction). Designed for citation: each section has a stable URL and a methodology version identifier you can reference in analysis output.
  - after: Fetch a PhaseFolio methodology section's full content (rNPV model, backtest, PoS calibration, IRA framework, development paths, deal-term modelling, holding valuation, clinical stage normalization, evidence standards, network benchmarks, COGS benchmark, SG&A benchmark, tax benchmark, SEC EDGAR deal-term extraction). Designed for citation: each section has a stable URL and a methodology version identifier you can reference in analysis output.
- 2026-09-28 `get_methodology` changed (description, inputSchema)
  - before: Fetch a PhaseFolio methodology section's full content (rNPV engine, backtest, PoS calibration, IRA framework, development paths, deal-term modelling, clinical stage normalization, evidence standards, network benchmarks, COGS benchmark, SG&A benchmark, tax benchmark, SEC EDGAR deal-term extraction). Designed for citation: each section has a stable URL and a methodology version identifier you can reference in analysis output.
  - after: Fetch a PhaseFolio methodology section's full content (rNPV model, backtest, PoS calibration, IRA framework, development paths, deal-term modelling, clinical stage normalization, evidence standards, network benchmarks, COGS benchmark, SG&A benchmark, tax benchmark, SEC EDGAR deal-term extraction). Designed for citation: each section has a stable URL and a methodology version identifier you can reference in analysis output.
- 2026-09-28 `triage_asset` changed (description)
  - before: Produce a transparent, provenance-linked CONDITIONAL READ on a drug asset for deal triage. Pass either `text` (a teaser/abstract — fields are machine-extracted and the result is marked inputs_unconfirmed) or pre-confirmed `fields`. Returns a reasoning chain (each claim grounded or marked insufficient_evidence), mechanism-plausibility flags, PoS metrics, and a meta block with engine/methodology/synthesis versions. Does NOT compute rNPV. Not an autonomous verdict.
  - after: Produce a transparent, provenance-linked CONDITIONAL READ on a drug asset for deal triage. Pass either `text` (a teaser/abstract — fields are machine-extracted and the result is marked inputs_unconfirmed) or pre-confirmed `fields`. Returns a reasoning chain (each claim grounded or marked insufficient_evidence), mechanism-plausibility flags, PoS metrics, and a meta block with model/methodology/synthesis versions. Does NOT compute rNPV. Not an autonomous verdict.
- 2026-09-28 `verify_export` changed (outputSchema)
- 2026-09-28 `query_benchmarks` changed (inputSchema)
- 2026-09-28 `query_drug_risk` changed (description, outputSchema)
  - before: Fetch human-reviewed drug-specific clinical-risk signals for a project, including biomarker quality, Phase 1 ORR flag-only data, provenance, extractor versions, and pending-review counts. Use this before interpreting engine 2.6.0 drug-specific multipliers or flags.
  - after: Fetch human-reviewed drug-specific clinical-risk signals for a project, including biomarker quality, Phase 1 ORR flag-only data, provenance, extractor versions, and pending-review counts. Use this before interpreting model 2.6.0 drug-specific multipliers or flags.
- 2026-09-28 `get_scenario` changed (description, outputSchema)
  - before: Fetch a PhaseFolio scenario's complete inputs (stage costs, durations, PoS, commercial assumptions, IRA settings) and computed outputs (eNPV, rNPV, cumulative PoS, per-stage breakdown, top sensitivity drivers). This is the authoritative engine output — every signed export ties back to this payload.
  - after: Fetch a PhaseFolio scenario's complete inputs (stage costs, durations, PoS, commercial assumptions, IRA settings) and computed outputs (eNPV, rNPV, cumulative PoS, per-stage breakdown, top sensitivity drivers). This is the authoritative model output — every signed export ties back to this payload.
- 2026-09-27 `get_methodology` changed (description, inputSchema, outputSchema)
  - before: Fetch a PhaseFolio methodology section's full content (rNPV engine, backtest, PoS calibration, IRA framework, development paths, clinical stage normalization, evidence standards, network benchmarks, COGS benchmark, SG&A benchmark, tax benchmark, SEC EDGAR deal-term extraction). Designed for citation: each section has a stable URL and a methodology version identifier you can reference in analysis output.
  - after: Fetch a PhaseFolio methodology section's full content (rNPV engine, backtest, PoS calibration, IRA framework, development paths, deal-term modelling, clinical stage normalization, evidence standards, network benchmarks, COGS benchmark, SG&A benchmark, tax benchmark, SEC EDGAR deal-term extraction). Designed for citation: each section has a stable URL and a methodology version identifier you can reference in analysis output.
- 2026-09-27 `query_sec_deal_terms` removed
  - Query SEC EDGAR deal-term extractions by indication, deal type, date range, confidence, and review state. Returns per-deal rows with source quotes and accession URLs for verification; aggregate engine medians use the separate backend aggregate function.
- 2026-09-27 `query_landscape` removed
  - Fetch the asset-anchored competitive landscape for a project — comparable trials, competing programs, sponsor activity, and biomarker overlap. Sourced from CT.gov + FDA + PhaseFolio's curated enrichment. Use when an analysis question asks 'who else is working on this?' or 'what's the competitive context?'

Full history: https://api.protogrid.dev/v1/servers/com.phasefolio%2Fphasefolio/changes

## Dependencies

- npm @phasefolio/mcp@0.1.4: resolved, 84 dependencies

Dependency graphs from deps.dev; advisories from OSV.dev, including the GitHub Advisory Database and the PyPI Advisory Database; all CC BY 4.0.

## Remotes

- https://app.phasefolio.com/api/mcp (streamable-http, auth none, reachable true, uptime30d 1)

## Packages

- npm @phasefolio/mcp@0.1.4 secrets: PHASEFOLIO_TOKEN

## Tools (10)

- `get_dossier`: Fetch the structured asset snapshot JSON for a scenario — the same content rendered in the PDF/Excel exports, in machine-readable form. Includes verdict, drivers, assumptions, evidence summary, and (if available) signed-export hashes pointing to the latest signed artifacts.
- `get_evidence`: Fetch the evidence register entries for a scenario — the citations, sources, and supporting documents the analyst attached to back the assumptions. Use this when an analysis question references 'what's the evidence for X?'
- `get_methodology`: Fetch a PhaseFolio methodology section's full content (rNPV model, backtest, PoS calibration, IRA framework, development paths, deal-term modelling, holding valuation, clinical stage normalization, evidence standards, network benchmarks, COGS benchmark, SG&A benchmark, tax benchmark, SEC EDGAR deal-term extraction). Designed for citation: each section has a stable URL and a methodology version identifier you can reference in analysis output.
- `get_project`: Fetch a PhaseFolio project's metadata: indication, sub-indication, modality, biomarker, asset name, and stage at entry. Use this when you need to ground an analysis question in the project's clinical context before fetching scenarios.
- `get_scenario`: Fetch a PhaseFolio scenario's complete inputs (stage costs, durations, PoS, commercial assumptions, IRA settings) and computed outputs (eNPV, rNPV, cumulative PoS, per-stage breakdown, top sensitivity drivers). This is the authoritative model output — every signed export ties back to this payload.
- `list_scenarios`: List all scenarios in a PhaseFolio project. Returns scenario IDs, names, created/updated timestamps, and top-line eNPV/rNPV. Use this to discover what scenarios exist before fetching one in detail.
- `query_benchmarks`: Query PhaseFolio benchmark availability. Source-backed PoS benchmarks are available separately; network cost distributions and duration percentiles are planned but currently return coming_soon with null estimates rather than PhaseFolio's manual planning defaults.
- `query_drug_risk`: Fetch human-reviewed drug-specific clinical-risk signals for a project, including biomarker quality, Phase 1 ORR flag-only data, provenance, extractor versions, and pending-review counts. Use this before interpreting model 2.6.0 drug-specific multipliers or flags.
- `triage_asset`: Produce a transparent, provenance-linked CONDITIONAL READ on a drug asset for deal triage. Pass either `text` (a teaser/abstract — fields are machine-extracted and the result is marked inputs_unconfirmed) or pre-confirmed `fields`. Returns a reasoning chain (each claim grounded or marked insufficient_evidence), mechanism-plausibility flags, PoS metrics, and a meta block with model/methodology/synthesis versions. Does NOT compute rNPV. Not an autonomous verdict.
- `verify_export`: Verify a signed PhaseFolio export by content hash. Returns verification status (valid/tampered/unknown), issued timestamp, methodology version, and an anonymized originating-org identifier. Use this when a user shares a PhaseFolio asset snapshot and you want to confirm it's authentic before citing the analysis.